1,027
Views
36
CrossRef citations to date
0
Altmetric
Research Paper

Contactless magneto-permeabilization for intracellular plasmid DNA delivery in-vivo

&
Pages 1707-1713 | Received 09 Jun 2012, Accepted 22 Jul 2012, Published online: 16 Aug 2012

References

  • Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012; 11:189 - 209; http://dx.doi.org/10.1586/erv.11.188; PMID: 22309668
  • Kaneda Y. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool. Expert Opin Drug Deliv 2010; 7:1079 - 93; http://dx.doi.org/10.1517/17425247.2010.510511; PMID: 20716020
  • Li S, ed. Electroporation Protocols: Preclinical and Clinical Gene Medicine. From Methods in Molecular Biology, Vol 423; Humana Press, New York, 2008.
  • Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164:4635 - 40; PMID: 10779767
  • Weiner DB. DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine 2008; 26:5073 - 4; http://dx.doi.org/10.1016/j.vaccine.2008.07.024; PMID: 18652867
  • Rabussay D. Applicator and electrode design for in vivo DNA delivery by electroporation. In: Li S, ed. Methods in molecular biology, New York:Humana Press, 2008:35-59.
  • Guo S, Donate A, Basu G, Lundberg C, Heller L, Heller R. Electro-gene transfer to skin using a noninvasive multielectrode array. J Control Release 2011; 151:256 - 62; http://dx.doi.org/10.1016/j.jconrel.2011.01.014; PMID: 21262290
  • Connolly RJ, Rey JI, Lambert VM, Wegerif G, Jaroszeski MJ, Ugen KE. Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma. Vaccine 2011; 29:6781 - 4; http://dx.doi.org/10.1016/j.vaccine.2010.12.054; PMID: 21195804
  • Broderick KE, Kardos T, McCoy JR, Fons MP, Kemmerrer S, Sardesai NY. Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity. Hum Vaccin 2011; 7:Suppl 22 - 8; http://dx.doi.org/10.4161/hv.7.0.14559; PMID: 21263230
  • Wallace M, Evans B, Woods S, Mogg R, Zhang L, Finnefrock AC, et al. Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults. Mol Ther 2009; 17:922 - 8; http://dx.doi.org/10.1038/mt.2009.27; PMID: 19277016
  • Kardos TJ, Rabussay DP. Method of contactless magnetic electroporation. U.S. patent application No. 12/732,195. 2010, pending.
  • Hofmann GA. Electroporetic gene and drug therapy. US patent No. 6,132,419. (2000).
  • Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1:841 - 5; PMID: 6329708
  • Breton M, Mir LM. Microsecond and nanosecond electric pulses in cancer treatments. Bioelectromagnetics 2011; In press PMID: 21812011
  • Miklavcic D, Mir LM, Vernier PT. Electroporation-based technologies and treatments. J Membr Biol 2010; 236:1 - 2; http://dx.doi.org/10.1007/s00232-010-9287-9; PMID: 20658230
  • Li S. Delivery of DNA into tumors. Methods Mol Biol 2008; 423:311 - 8; http://dx.doi.org/10.1007/978-1-59745-194-9_23; PMID: 18370209
  • Gehl J. Electroporation for drug and gene delivery in the clinic: doctors go electric. Methods Mol Biol 2008; 423:351 - 9; http://dx.doi.org/10.1007/978-1-59745-194-9_27; PMID: 18370213
  • Andre FM, Mir LM. Nucleic acids electrotransfer in vivo: mechanisms and practical aspects. Curr Gene Ther 2010; 10:267 - 80; http://dx.doi.org/10.2174/156652310791823380; PMID: 20557285
  • Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26:5896 - 903; PMID: 19029422
  • Muthumani K, Lambert VM, Kawalekar O, Heller R, Kim JJ, Weiner DB, et al. Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides. Vaccine 2010; 28:2005 - 10; http://dx.doi.org/10.1016/j.vaccine.2009.10.060; PMID: 20188256
  • Babiuk S, Baca-Estrada ME, Foldvari M, Baizer L, Stout R, Storms M, et al. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther 2003; 8:992 - 8; http://dx.doi.org/10.1016/j.ymthe.2003.09.008; PMID: 14664802
  • Prud’homme GJ, Draghia-Akli R, Wang Q. Plasmid-based gene therapy of diabetes mellitus. Gene Ther 2007; 14:553 - 64; http://dx.doi.org/10.1038/sj.gt.3302907; PMID: 17215847
  • Ueno S. Studies on magnetism and bioelectromagnetics for 45 years: from magnetic analog memory to human brain stimulation and imaging. Bioelectromagnetics 2012; 33:3 - 22; http://dx.doi.org/10.1002/bem.20714; PMID: 22012916

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.